About
Oral liver therapy
Areas of Focus
Categories
Small Molecule PharmaceuticalMiddle East
Team (22)
Allen Baharaff
Galmed Pharmaceuticals
team_member
Amir Poshinski
Galmed Pharmaceuticals
team_member
Carol L. Brosgart, M.D.
Galmed Pharmaceuticals
team_member
Dalia Medini, Ph.D.
Galmed Pharmaceuticals
team_member
David Sidransky, M.D.
Galmed Pharmaceuticals
team_member
Doron Cohen
Galmed Pharmaceuticals
team_member
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
11
As Collaborator
0
Total Enrollment
339
By Phase
PHASE2: 2PHASE1: 7PHASE3: 1PHASE2/PHASE3: 1
By Status
COMPLETED: 7WITHDRAWN: 1ACTIVE_NOT_RECRUITING: 1UNKNOWN: 1TERMINATED: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06095986Lead Sponsor
A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis
PHASE2Withdrawn
Started: Jun 30, 2025 · Completed: Dec 31, 2027
NCT06502561Lead Sponsor
Comparing The PK Of Aramchol Meglumine Granules To Aramchol Free Acid Tablets
PHASE1Active, not recruiting
16 participants
Started: Feb 15, 2025 · Completed: May 31, 2025
NCT05857215Lead Sponsor
A First-in-Human Study of Single and Multiple Doses of Amilo-5MER in Healthy Subjects
PHASE1Completed
55 participants
Started: Mar 5, 2021 · Completed: Jul 1, 2021
NCT05874336Lead Sponsor
An Open-Label, Two-Part Study Designed to Assess the Absolute Bioavailability and Mass Balance of Aramchol
PHASE1Completed
6 participants
Started: Jun 17, 2020 · Completed: Aug 11, 2020
NCT03774173Lead Sponsor
Comparison of Aramchol Concentrations With Once or Twice Daily Dosing
PHASE1Completed
16 participants
Started: Dec 8, 2018 · Completed: Mar 5, 2019
Locations (1)
Headquarters
Tel Aviv, Israel
Map
Loading map...